Learn more about the sacroiliac joint at http://sibone.com.

It is commonly reported in clinical literature that up to 25% of all low back pain is caused by the SI joint. Once nonsurgical options have been tried and do not provide relief, your surgeon may consider other options, including surgery.

SIBONE, Inc. has developed a minimally invasive surgical (MIS), innovative, patented, implant system for certain sacroiliac (SI) joint problems. The iFuse Implant System® consists of titanium implants and associated surgical instruments.

The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.

There are potential risks associated with the iFuse Implant
System. It may not be appropriate for all patients and all
patients may not benefit. For information about the risks,
visit: www.sibone.com/risks

(C) 2017. SIBONE, Inc. All rights reserved.SIBONE and iFuse Implant System are registered trademarks of SIBONE, Inc.

U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; 9,561,063; pending U.S. and foreign patent applications.

8823 030315